Science and Technology Committee (Commons)

Clinical trials transparency: follow-up inquiry - publications

Inquiry status: Concluded

Due to the general election on 12 December 2019 the Committee has now closed this inquiry. Following the dissolution of Parliament on 6 November, all Select Committees will cease to exist until after the general election. If an inquiry on this subject is held in the future, the Committee may refer to the evidence already gathered as part of this inquiry.

Oral evidence

  • 29 Oct 2019 - Clinical trials transparency: follow-up - oral evidence | PDF version (PDF374 KB) HC 139 | Published 04 Nov 2019

    Evidence given by Professor Jane Eddleston, Joint Group Medical Director, Manchester University NHS Foundation Trust, Professor Nigel Brunskill, Director of Research and Innovation, University Hospitals of Leicester NHS Trust, Mark Cranmer, Director, Joint Research and Enterprise Services, St George’s, University of London and St George's University Hospitals NHS Foundation Trust, Professor Rupert Pearse, Clinical Director of Research and Development, Queen Mary University of London and Barts Health NHS Trust, and Dr Síle Lane, Head of International Campaigns and Policy, Sense about Science; Dr Martin O'Kane, Medicines and Healthcare products Regulatory Agency, Head of Clinical Trials Unit, Dr Fiona Godlee, Editor in Chief, British Medical Journal, Juliet Tizzard, Director of Policy, and Professor Sir Terence Stephenson, Chair, Health Research Authority

    Watch this evidence session

Written evidence

Receive RSS updates

Share this page